PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) Blues. Beije N, Abida W, Antonarakis ES, Castro E, et al. Eur Urol 2023 Apr 20:S0302-2838(23)02716-1. doi: 10.1016/j.eururo.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Beije N, Abida W, Antonarakis ES, Castro E, et al. PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) Blues. Eur Urol 2023 Apr 20:S0302-2838(23)02716-1. doi: 10.1016/j.eururo.2023.
PMID: 37087376